SHBG and breast carcinoma: For example, both pre- and post-diagnostic circulating 17β-estradiol concentrations, but not testosterone and sex hormone-binding globulin concentrations, have been shown to be associated with poorer survival in postmenopausal breast cancer patients and risk of recurrence in patients with early stage breast cancer [12, 39].